Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Mounjaro ® ▼ (tirzepatide)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
How to dial a dose with the Mounjaro® (tirzepatide) KwikPen®
Before dialing a dose, prepare the injection and prime the pen as described in the instructions for use. To dial a dose, turn the dose knob until it stops and the "1" is visible in the dose window.
Please note: A modified version of the Mounjaro KwikPen will be available on the market at the same time as the initial version. While the two versions may look slightly different, they work in the same way.1 The information provided in this document applies to both the modified and initial KwikPens.
How to confirm the dose is dialled
Turn the dose knob until it stops and the 
icon is shown in the dose window.2
The icon is equal to a full 0.6 mL dose.2
References
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2Mounjaro [instructions for use]. Eli Lilly Nederland B.V., The Netherlands. (UK)
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: 15 August 2025